Zeder Katarina, Sassmann Teresa, Foris Vasile, Douschan Philipp, Olschewski Horst, Kovacs Gabor
Division of Pulmonology, Medical University of Graz, Austria.
Ludwig Boltzmann Institute for Lung Vascular Research Graz, Austria.
Int J Cardiol Congenit Heart Dis. 2024 Jun 12;17:100519. doi: 10.1016/j.ijcchd.2024.100519. eCollection 2024 Sep.
Severe pulmonary hypertension (PH) in chronic obstructive pulmonary disease (COPD) is currently defined by an elevated mean pulmonary arterial pressure and strongly elevated pulmonary vascular resistance >5 wood units. Clinically, these patients show a male predominance, and usually present with very severe dyspnea, severe hypoxemia, strongly decreased exercise capacity and poor prognosis, even though the clinical picture is frequently associated with less severe airflow obstruction. Explanted lung samples of patients with COPD and severe PH show severe remodeling of small pulmonary arterioles, predominantly in the intima and media of the vessels. In this concise review, we discuss the clinical and histopathological evidence of severe PH in COPD.
慢性阻塞性肺疾病(COPD)中的重度肺动脉高压(PH)目前定义为平均肺动脉压升高且肺血管阻力显著升高>5 伍德单位。临床上,这些患者以男性居多,通常表现为非常严重的呼吸困难、严重低氧血症、运动能力严重下降和预后不良,尽管临床表现常与不太严重的气流阻塞相关。COPD 合并重度 PH 患者的肺移植样本显示小肺动脉严重重塑,主要发生在血管的内膜和中膜。在这篇简短的综述中,我们讨论了 COPD 中重度 PH 的临床和组织病理学证据。